ARTICLE | Company News
Power3, Methodist Hospital Research Institute deal
July 25, 2005 7:00 AM UTC
Power3 and the institute partnered to identify biomarkers for amyotrophic lateral sclerosis (ALS), Alzheimer's disease (AD) and Parkinson's disease (PD). The deal combines PWRM's proteomics technologi...